Research graph
References from Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/bph.70230
10.1111/bph.70230 · External reference
10.1111/bph.70234
10.1111/bph.70234 · External reference
10.1186/s40478-015-0187-1
10.1186/s40478-015-0187-1 · External reference
10.1146/annurev.neuro.28.061604.135709
10.1146/annurev.neuro.28.061604.135709 · External reference
10.1016/j.stemcr.2021.01.019
10.1016/j.stemcr.2021.01.019 · External reference
10.1002/hipo.22388
10.1002/hipo.22388 · External reference
10.1038/s42003-024-05949-5
10.1038/s42003-024-05949-5 · External reference
Neuropathological changes and amyloid‐related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: A retrospective case‐control study
10.1016/s1474-4422(25)00313-8 · 2025 · External reference
10.1016/j.neuron.2010.11.022
10.1016/j.neuron.2010.11.022 · External reference
10.3389/fimmu.2022.856376
10.3389/fimmu.2022.856376 · External reference
10.1186/s12974-024-03180-x
10.1186/s12974-024-03180-x · External reference
10.1523/jneurosci.2833-20.2021
10.1523/jneurosci.2833-20.2021 · External reference
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric abeta, and frank neuronal loss
10.1523/jneurosci.3672-12.2013 · 2013 · External reference
10.1111/bph.17441
10.1111/bph.17441 · External reference
10.3233/jad-171018
10.3233/jad-171018 · External reference
10.1038/s41586-026-10169-4
10.1038/s41586-026-10169-4 · External reference
10.1111/jnc.13447
10.1111/jnc.13447 · External reference
10.7554/elife.100822
10.7554/elife.100822 · External reference
Unresolved reference
2025 · External reference
10.1016/j.cell.2016.10.021
10.1016/j.cell.2016.10.021 · External reference
10.3389/fnagi.2010.00150
10.3389/fnagi.2010.00150 · External reference
10.1002/ibra.12023
10.1002/ibra.12023 · External reference
10.3390/biomedicines10020436
10.3390/biomedicines10020436 · External reference
10.1038/s41380-021-01249-0
10.1038/s41380-021-01249-0 · External reference
10.1073/pnas.0909586107
10.1073/pnas.0909586107 · External reference
NIA‐AA research framework: Toward a biological definition of Alzheimer's disease
10.1016/j.jalz.2018.02.018 · 2018 · External reference
10.3233/jad-210311
10.3233/jad-210311 · External reference
10.1038/s41598-019-43076-y
10.1038/s41598-019-43076-y · External reference
10.1186/s40478-017-0411-2
10.1186/s40478-017-0411-2 · External reference
10.3233/jad-190090
10.3233/jad-190090 · External reference
10.1046/j.1460-9568.2003.02716.x
10.1046/j.1460-9568.2003.02716.x · External reference
10.1186/s13195-022-01002-x
10.1186/s13195-022-01002-x · External reference
Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
10.2165/00002512-200016050-00006 · 2000 · External reference
10.1016/j.vascn.2013.05.003
10.1016/j.vascn.2013.05.003 · External reference
10.1186/s13041-024-01092-8
10.1186/s13041-024-01092-8 · External reference
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
10.1093/brain/awab452 · 2022 · External reference
10.1111/bph.15178
10.1111/bph.15178 · External reference
10.3233/jad-141062
10.3233/jad-141062 · External reference
10.1097/01.mpg.0000226379.41365.62
10.1097/01.mpg.0000226379.41365.62 · External reference
10.1016/j.jalz.2011.03.005
10.1016/j.jalz.2011.03.005 · External reference
10.1002/alz.12582
10.1002/alz.12582 · External reference
10.1016/j.nlm.2015.11.014
10.1016/j.nlm.2015.11.014 · External reference
10.1016/s0896-6273(00)81109-5
10.1016/s0896-6273(00)81109-5 · External reference
10.1007/s00401-011-0884-1
10.1007/s00401-011-0884-1 · External reference
10.3233/jad-2010-1221
10.3233/jad-2010-1221 · External reference
10.1146/annurev.neuro.26.041002.131445
10.1146/annurev.neuro.26.041002.131445 · External reference
10.1007/s12035-025-05474-4
10.1007/s12035-025-05474-4 · External reference
10.1002/alz.70532
10.1002/alz.70532 · External reference
10.1016/0149-7634(85)90050-8
10.1016/0149-7634(85)90050-8 · External reference
10.1101/lm.031088.113
10.1101/lm.031088.113 · External reference
10.1002/trc2.70217
10.1002/trc2.70217 · External reference
10.1016/j.chom.2025.10.005
10.1016/j.chom.2025.10.005 · External reference
10.3389/fnagi.2012.00017
10.3389/fnagi.2012.00017 · External reference
10.1371/journal.pbio.3000410
10.1371/journal.pbio.3000410 · External reference
10.1590/1980-5764-dn-2024-0204
10.1590/1980-5764-dn-2024-0204 · External reference
10.3389/fnmol.2019.00334
10.3389/fnmol.2019.00334 · External reference
Dopamine and noradrenaline in the brain; overlapping or dissociate functions?
10.3389/fnmol.2019.00334 · 2020 · External reference
10.1016/j.beproc.2023.104912
10.1016/j.beproc.2023.104912 · External reference
10.1007/s00702-023-02692-9
10.1007/s00702-023-02692-9 · External reference
10.1007/s11357-024-01359-x
10.1007/s11357-024-01359-x · External reference
10.1002/alz.70213
10.1002/alz.70213 · External reference
10.1093/brain/aww214
10.1093/brain/aww214 · External reference
10.1097/00005072-199911000-00002
10.1097/00005072-199911000-00002 · External reference
10.1016/s0022-510x(00)00285-9
10.1016/s0022-510x(00)00285-9 · External reference
10.2174/1570159x15666170510143821
10.2174/1570159x15666170510143821 · External reference
10.1002/ana.410300410
10.1002/ana.410300410 · External reference
10.1002/alz.14258
10.1002/alz.14258 · External reference
10.1016/j.jalz.2016.06.2362
10.1016/j.jalz.2016.06.2362 · External reference
10.3389/fnbeh.2021.667244
10.3389/fnbeh.2021.667244 · External reference
10.1101/cshperspect.a018903
10.1101/cshperspect.a018903 · External reference
10.1016/j.neubiorev.2013.05.008
10.1016/j.neubiorev.2013.05.008 · External reference
10.1038/s41586-018-0682-1
10.1038/s41586-018-0682-1 · External reference
10.1038/nprot.2007.44
10.1038/nprot.2007.44 · External reference
Beta‐amyloid degradation and Alzheimer's disease
2006 · External reference
10.1126/scisignal.adk1822
10.1126/scisignal.adk1822 · External reference
Neural reserve, neuronal density in the locus coeruleus, and cognitive decline
10.1212/wnl.0b013e3182897103 · 2013 · External reference
10.1016/b0-08-043076-7/03460-4
10.1016/b0-08-043076-7/03460-4 · 2001 · External reference
10.3233/jad-230199
10.3233/jad-230199 · External reference
10.1038/s41380-021-01092-3
10.1038/s41380-021-01092-3 · External reference
10.3390/biomedicines7040097
10.3390/biomedicines7040097 · External reference
10.1038/s44319-024-00090-0
10.1038/s44319-024-00090-0 · External reference
10.1002/alz.12582
10.1002/alz.12582 · ExternalCitation · doi-reference
10.1002/alz.14258
10.1002/alz.14258 · ExternalCitation · doi-reference
10.1002/alz.70213
10.1002/alz.70213 · ExternalCitation · doi-reference
10.1002/alz.70532
10.1002/alz.70532 · ExternalCitation · doi-reference
10.1002/ana.410300410
10.1002/ana.410300410 · ExternalCitation · doi-reference
10.1002/hipo.22388
10.1002/hipo.22388 · ExternalCitation · doi-reference
10.1002/ibra.12023
10.1002/ibra.12023 · ExternalCitation · doi-reference
10.1002/trc2.70217
10.1002/trc2.70217 · ExternalCitation · doi-reference
10.1007/s00401-011-0884-1
10.1007/s00401-011-0884-1 · ExternalCitation · doi-reference
10.1007/s00702-023-02692-9
10.1007/s00702-023-02692-9 · ExternalCitation · doi-reference
10.1007/s11357-024-01359-x
10.1007/s11357-024-01359-x · ExternalCitation · doi-reference
10.1007/s12035-025-05474-4
10.1007/s12035-025-05474-4 · ExternalCitation · doi-reference
10.1016/0149-7634(85)90050-8
10.1016/0149-7634(85)90050-8 · ExternalCitation · doi-reference
10.1016/b0-08-043076-7/03460-4
10.1016/b0-08-043076-7/03460-4 · ExternalCitation · doi-reference
10.1016/j.beproc.2023.104912
10.1016/j.beproc.2023.104912 · ExternalCitation · doi-reference
10.1016/j.cell.2016.10.021
10.1016/j.cell.2016.10.021 · ExternalCitation · doi-reference
10.1016/j.chom.2025.10.005
10.1016/j.chom.2025.10.005 · ExternalCitation · doi-reference
10.1016/j.jalz.2011.03.005
10.1016/j.jalz.2011.03.005 · ExternalCitation · doi-reference
10.1016/j.jalz.2016.06.2362
10.1016/j.jalz.2016.06.2362 · ExternalCitation · doi-reference
NIA‐AA research framework: Toward a biological definition of Alzheimer's disease
10.1016/j.jalz.2018.02.018 · ExternalCitation · doi-reference
10.1016/j.neubiorev.2013.05.008
10.1016/j.neubiorev.2013.05.008 · ExternalCitation · doi-reference
10.1016/j.neuron.2010.11.022
10.1016/j.neuron.2010.11.022 · ExternalCitation · doi-reference
10.1016/j.nlm.2015.11.014
10.1016/j.nlm.2015.11.014 · ExternalCitation · doi-reference
10.1016/j.stemcr.2021.01.019
10.1016/j.stemcr.2021.01.019 · ExternalCitation · doi-reference
10.1016/j.vascn.2013.05.003
10.1016/j.vascn.2013.05.003 · ExternalCitation · doi-reference
10.1016/s0022-510x(00)00285-9
10.1016/s0022-510x(00)00285-9 · ExternalCitation · doi-reference
10.1016/s0896-6273(00)81109-5
10.1016/s0896-6273(00)81109-5 · ExternalCitation · doi-reference
Neuropathological changes and amyloid‐related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: A retrospective case‐control study
10.1016/s1474-4422(25)00313-8 · ExternalCitation · doi-reference
10.1038/nprot.2007.44
10.1038/nprot.2007.44 · ExternalCitation · doi-reference
10.1038/s41380-021-01092-3
10.1038/s41380-021-01092-3 · ExternalCitation · doi-reference
10.1038/s41380-021-01249-0
10.1038/s41380-021-01249-0 · ExternalCitation · doi-reference
10.1038/s41586-018-0682-1
10.1038/s41586-018-0682-1 · ExternalCitation · doi-reference
10.1038/s41586-026-10169-4
10.1038/s41586-026-10169-4 · ExternalCitation · doi-reference
10.1038/s41598-019-43076-y
10.1038/s41598-019-43076-y · ExternalCitation · doi-reference
10.1038/s42003-024-05949-5
10.1038/s42003-024-05949-5 · ExternalCitation · doi-reference
10.1038/s44319-024-00090-0
10.1038/s44319-024-00090-0 · ExternalCitation · doi-reference
10.1046/j.1460-9568.2003.02716.x
10.1046/j.1460-9568.2003.02716.x · ExternalCitation · doi-reference
10.1073/pnas.0909586107
10.1073/pnas.0909586107 · ExternalCitation · doi-reference
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
10.1093/brain/awab452 · ExternalCitation · doi-reference
10.1093/brain/aww214
10.1093/brain/aww214 · ExternalCitation · doi-reference
10.1097/00005072-199911000-00002
10.1097/00005072-199911000-00002 · ExternalCitation · doi-reference
10.1097/01.mpg.0000226379.41365.62
10.1097/01.mpg.0000226379.41365.62 · ExternalCitation · doi-reference
10.1101/cshperspect.a018903
10.1101/cshperspect.a018903 · ExternalCitation · doi-reference
10.1101/lm.031088.113
10.1101/lm.031088.113 · ExternalCitation · doi-reference
10.1111/bph.15178
10.1111/bph.15178 · ExternalCitation · doi-reference
10.1111/bph.17441
10.1111/bph.17441 · ExternalCitation · doi-reference
10.1111/bph.70230
10.1111/bph.70230 · ExternalCitation · doi-reference
10.1111/bph.70234
10.1111/bph.70234 · ExternalCitation · doi-reference
10.1111/jnc.13447
10.1111/jnc.13447 · ExternalCitation · doi-reference
10.1126/scisignal.adk1822
10.1126/scisignal.adk1822 · ExternalCitation · doi-reference
10.1146/annurev.neuro.26.041002.131445
10.1146/annurev.neuro.26.041002.131445 · ExternalCitation · doi-reference
10.1146/annurev.neuro.28.061604.135709
10.1146/annurev.neuro.28.061604.135709 · ExternalCitation · doi-reference
10.1186/s12974-024-03180-x
10.1186/s12974-024-03180-x · ExternalCitation · doi-reference
10.1186/s13041-024-01092-8
10.1186/s13041-024-01092-8 · ExternalCitation · doi-reference
10.1186/s13195-022-01002-x
10.1186/s13195-022-01002-x · ExternalCitation · doi-reference
10.1186/s40478-015-0187-1
10.1186/s40478-015-0187-1 · ExternalCitation · doi-reference
10.1186/s40478-017-0411-2
10.1186/s40478-017-0411-2 · ExternalCitation · doi-reference
Neural reserve, neuronal density in the locus coeruleus, and cognitive decline
10.1212/wnl.0b013e3182897103 · ExternalCitation · doi-reference
10.1371/journal.pbio.3000410
10.1371/journal.pbio.3000410 · ExternalCitation · doi-reference
10.1523/jneurosci.2833-20.2021
10.1523/jneurosci.2833-20.2021 · ExternalCitation · doi-reference
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric abeta, and frank neuronal loss
10.1523/jneurosci.3672-12.2013 · ExternalCitation · doi-reference
10.1590/1980-5764-dn-2024-0204
10.1590/1980-5764-dn-2024-0204 · ExternalCitation · doi-reference
Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
10.2165/00002512-200016050-00006 · ExternalCitation · doi-reference
10.2174/1570159x15666170510143821
10.2174/1570159x15666170510143821 · ExternalCitation · doi-reference
10.3233/jad-141062
10.3233/jad-141062 · ExternalCitation · doi-reference
10.3233/jad-171018
10.3233/jad-171018 · ExternalCitation · doi-reference
10.3233/jad-190090
10.3233/jad-190090 · ExternalCitation · doi-reference
10.3233/jad-2010-1221
10.3233/jad-2010-1221 · ExternalCitation · doi-reference
10.3233/jad-210311
10.3233/jad-210311 · ExternalCitation · doi-reference
10.3233/jad-230199
10.3233/jad-230199 · ExternalCitation · doi-reference
10.3389/fimmu.2022.856376
10.3389/fimmu.2022.856376 · ExternalCitation · doi-reference
10.3389/fnagi.2010.00150
10.3389/fnagi.2010.00150 · ExternalCitation · doi-reference
10.3389/fnagi.2012.00017
10.3389/fnagi.2012.00017 · ExternalCitation · doi-reference
10.3389/fnbeh.2021.667244
10.3389/fnbeh.2021.667244 · ExternalCitation · doi-reference
Dopamine and noradrenaline in the brain; overlapping or dissociate functions?
10.3389/fnmol.2019.00334 · ExternalCitation · doi-reference
10.3390/biomedicines10020436
10.3390/biomedicines10020436 · ExternalCitation · doi-reference
10.3390/biomedicines7040097
10.3390/biomedicines7040097 · ExternalCitation · doi-reference
10.7554/elife.100822
10.7554/elife.100822 · ExternalCitation · doi-reference
